TERN
Terns Pharmaceuticals, Inc. · Healthcare
Vivo Opportunity, LLC bought $2.2M of Terns Pharmaceuticals, Inc.
10% owner
Bought$2,160,000
$3.60Price
600,000Shares
+11%Stake
What TERN did for a copier
- $1,000 copied at Fri, Sep 9 open, $4.72
- $1,436
- S&P 500, same days
- −6.7%
Measured over 30 trading days, to the Oct 21 close.
Vivo Opportunity, LLC's record
4 other buys with 3 months of prices since 2022: on average +15.5% against the S&P 500, and 1 of 4 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Sep 7. Filed Thu, Sep 8, 8:00 PM ET, after the close. Returns use the Sep 9 open and the Oct 21 close. Not investment advice.